Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Why Indices Rise Or Fall
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,058 articles
EUROPOL Dismantles Crypto-Linked Proxy Network SocksEscort
A joint DOJ-EUROPOL operation has dismantled SocksEscort, a long-running crypto-linked proxy network used to mask cyb...
Coinbase Bybit Talks Strategic Investment Tie-Up Rumor
Coinbase and Bybit are in early-stage talks about a strategic investment partnership that could pave the way for Bybi...
Your First Next) Rental: A Step‑By‑Step Guide for 2026
Thinking about your first next) rental in 2026? This practical guide breaks down financing, deal analysis, and smart ...
Magnificent Stocks Have Split: Only Two Beat the Market
Since 2020, five magnificent stocks have split their shares. Only Alphabet and Tesla outpaced the market, proving tha...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Is Walmart a Recession-Proof Stock? What Investors Must Know
As economies slow, shoppers pivot toward essentials and value. This article dives into whether walmart recession-proo...
This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Mastercard Acquire Crypto Startup BVNK for Up to $1.8B
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
AI Isn’t Killing Consultants Yet, Capgemini Strategy Chief
Capgemini’s strategy chief says the idea that AI will eliminate consultants is overstated, arguing transformation wor...
ClearPoint Neuro (CLPT) Earnings Outlook for Investors
ClearPoint Neuro's earnings are under the microscope for investors watching the medical-device niche. This analysis b...
Benchmark Cuts Price Target for Bakkt by Nearly 50%
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status